240 related articles for article (PubMed ID: 30777199)
1. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
[TBL] [Abstract][Full Text] [Related]
2. Assessing Microcirculation in Resectable Oesophageal Squamous Cell Carcinoma with Dynamic Contrast-enhanced MRI for Identifying Primary tumour and Lymphatic Metastasis.
Chen YL; Jiang Y; Chen TW; Li R; Zhang XM; Chen F; Wu L; Ou J; Yang JQ
Sci Rep; 2019 Jan; 9(1):124. PubMed ID: 30644415
[TBL] [Abstract][Full Text] [Related]
3. Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.
Sun K; Zhu H; Chai W; Zhan Y; Nickel D; Grimm R; Fu C; Yan F
Eur Radiol; 2020 Jan; 30(1):57-65. PubMed ID: 31372782
[TBL] [Abstract][Full Text] [Related]
4. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
5. Predicting T and N Staging of Resectable Gastric Cancer According to Whole Tumor Histogram Analysis About a Non-Cartesian k-Space Acquisition DCE-MRI: A Feasibility Study.
Yan L; Qu J; Li J; Zhang H; Lu Y; Gao J
Cancer Manag Res; 2021; 13():7951-7960. PubMed ID: 34703316
[TBL] [Abstract][Full Text] [Related]
6. Tumour volume of resectable oesophageal squamous cell carcinoma measured with MRI correlates well with T category and lymphatic metastasis.
Wu L; Ou J; Chen TW; Li R; Zhang XM; Chen YL; Jiang Y; Yang JQ; Cao JM
Eur Radiol; 2018 Nov; 28(11):4757-4765. PubMed ID: 29761360
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
Xu L; Ge X; Sun N; Liu X
Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
[TBL] [Abstract][Full Text] [Related]
8. Tumour size of resectable oesophageal squamous cell carcinoma measured with multidetector computed tomography for predicting regional lymph node metastasis and N stage.
Li H; Chen TW; Li ZL; Zhang XM; Chen XL; Wang LY; Zhou L; Li R; Li CP; Huang XH
Eur Radiol; 2012 Nov; 22(11):2487-93. PubMed ID: 22653286
[TBL] [Abstract][Full Text] [Related]
9. Application of Dynamic Contrast-Enhanced MRI Parameters for Differentiating Squamous Cell Carcinoma and Malignant Lymphoma of the Oropharynx.
Park M; Kim J; Choi YS; Lee SK; Koh YW; Kim SH; Choi EC
AJR Am J Roentgenol; 2016 Feb; 206(2):401-7. PubMed ID: 26797371
[TBL] [Abstract][Full Text] [Related]
10. Intravoxel incoherent motion diffusion-weighted imaging of resectable oesophageal squamous cell carcinoma: association with tumour stage.
Huang YC; Chen TW; Zhang XM; Zeng NL; Li R; Tang YL; Chen F; Chen YL
Br J Radiol; 2018 Apr; 91(1084):20170421. PubMed ID: 29308923
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between Luminal A and B Molecular Subtypes of Breast Cancer Using Pharmacokinetic Quantitative Parameters with Histogram and Texture Features on Preoperative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Luo HB; Du MY; Liu YY; Wang M; Qing HM; Wen ZP; Xu GH; Zhou P; Ren J
Acad Radiol; 2020 Mar; 27(3):e35-e44. PubMed ID: 31151899
[TBL] [Abstract][Full Text] [Related]
12. Correlation of MRI quantitative perfusion parameters with EGFR, VEGF and EGFR gene mutations in non-small cell cancer.
Zou M; Zhang B; Shi L; Mao H; Huang Y; Zhao Z
Sci Rep; 2024 Feb; 14(1):4447. PubMed ID: 38396128
[TBL] [Abstract][Full Text] [Related]
13. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
[TBL] [Abstract][Full Text] [Related]
14. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
Sun NN; Ge XL; Liu XS; Xu LL
Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
[TBL] [Abstract][Full Text] [Related]
15. Correlation between quantitative perfusion histogram parameters of DCE-MRI and PTEN, P-Akt and m-TOR in different pathological types of lung cancer.
Zhang B; Zhao Z; Huang Y; Mao H; Zou M; Wang C; Yu G; Zhang M
BMC Med Imaging; 2021 Apr; 21(1):73. PubMed ID: 33865336
[TBL] [Abstract][Full Text] [Related]
16. Whole solid tumor volume histogram parameters for predicting the recurrence in patients with epithelial ovarian carcinoma: a feasibility study on quantitative DCE-MRI.
Li HM; Tang W; Feng F; Zhao SH; Gu WY; Zhang GF; Qiang JW
Acta Radiol; 2020 Sep; 61(9):1266-1276. PubMed ID: 31955611
[TBL] [Abstract][Full Text] [Related]
17. Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma.
Surov A; Meyer HJ; Leifels L; Höhn AK; Richter C; Winter K
Oncotarget; 2018 Apr; 9(30):21070-21077. PubMed ID: 29765520
[TBL] [Abstract][Full Text] [Related]
18. Histogram analysis of diffusion-weighted imaging and dynamic contrast-enhanced MRI for predicting occult lymph node metastasis in early-stage oral tongue squamous cell carcinoma.
Ren J; Yuan Y; Tao X
Eur Radiol; 2022 Apr; 32(4):2739-2747. PubMed ID: 34642806
[TBL] [Abstract][Full Text] [Related]
19. Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.
Zhang Y; Li Z; Gao C; Shen J; Chen M; Liu Y; Cao Z; Pang P; Cui F; Xu M
Cancer Med; 2021 Jul; 10(13):4240-4249. PubMed ID: 34117733
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
